Data is not available at this time.
HeiQ Plc is a Swiss-based innovator in functional textile technologies, specializing in antimicrobial fabrics and advanced textile chemicals. The company serves global markets, including Europe, the Americas, and Asia, with a focus on intimate apparel, sportswear, and home fashion brands. Its revenue model combines B2B sales of proprietary textile treatments with value-added services like regulatory compliance, technical support, and product development. HeiQ operates in the highly competitive consumer cyclical sector, where differentiation through performance-enhancing technologies is critical. The company has positioned itself as a leader in sustainable and high-performance textile solutions, leveraging its R&D capabilities to address growing demand for hygiene-conscious and eco-friendly fabrics. Its market position is reinforced by partnerships with global brands seeking to integrate advanced functionalities into their products. However, the sector faces challenges from raw material volatility and shifting consumer preferences, requiring continuous innovation to maintain competitive advantage.
In FY 2023, HeiQ reported revenue of 41.7 million GBP, reflecting its niche market presence. However, the company posted a net loss of 13.6 million GBP, with diluted EPS at -0.0967 GBP, indicating profitability challenges. Operating cash flow was negative at 3.3 million GBP, exacerbated by capital expenditures of 1.4 million GBP, suggesting strained liquidity amid ongoing investments in technology and market expansion.
HeiQ's negative earnings and cash flow highlight inefficiencies in converting revenue to profit, likely due to high R&D and operational costs inherent in its innovation-driven model. The company's capital allocation appears focused on sustaining its technological edge, but the lack of positive earnings raises questions about near-term scalability and return on invested capital in a competitive textile chemicals market.
HeiQ's balance sheet shows 9.7 million GBP in cash against 19.7 million GBP in total debt, indicating a leveraged position. The negative operating cash flow further strains liquidity, though the company’s moderate market cap (7.6 million GBP) and beta (0.688) suggest lower volatility relative to broader markets. Financial health remains a concern given the debt burden and ongoing cash burn.
HeiQ’s growth is tied to adoption of its functional textiles, but recent financials show no dividend payouts, aligning with its reinvestment strategy. The lack of profitability trends raises uncertainty about sustainable growth, though the antimicrobial fabric market’s expansion could present long-term opportunities if the company achieves operational scale.
The market values HeiQ at 7.6 million GBP, reflecting skepticism about its path to profitability. The low beta suggests muted investor expectations, with the stock likely pricing in execution risks in a capital-intensive sector. Valuation metrics are challenged by negative earnings, leaving future performance contingent on revenue growth and cost management.
HeiQ’s strengths lie in its specialized IP and B2B partnerships, but macroeconomic pressures and high R&D costs pose near-term hurdles. Success depends on commercializing innovations and improving margins. The outlook remains cautious unless the company demonstrates sustainable profitability or secures strategic alliances to bolster its market position.
Company filings, London Stock Exchange data
show cash flow forecast
| Fiscal year | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |